David P. Hochman - 10 Dec 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Chief Executive Officer and Chairperson, Director
Signature
/s/ Andrew Taylor, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
10 Dec 2025
Net transactions value
-$203,789
Form type
4
Filing time
12 Dec 2025, 16:15:15 UTC
Previous filing
17 Nov 2025
Next filing
13 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hochman David P Chief Executive Officer and Chairperson, Director C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE /s/ Andrew Taylor, Attorney-in-Fact 12 Dec 2025 0001292834

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Tax liability $188,458 -40,355 -6.6% $4.67 572,467 10 Dec 2025 Direct F1
transaction OBIO Common Stock Tax liability $15,332 -3,283 -0.74% $4.67 439,482 10 Dec 2025 By the DPH 2008 Trust F1
holding OBIO Common Stock 2,000 10 Dec 2025 By the Solomon Ascher Hochman 2019 Trust
holding OBIO Common Stock 2,000 10 Dec 2025 By the Hannah Hochman 2019 Trust
holding OBIO Common Stock 2,000 10 Dec 2025 By the Judah Herman Hochman 2019 Trust
holding OBIO Common Stock 3,140 10 Dec 2025 By the NSH 2008 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

Remarks:

Chief Executive Officer and Chairperson